DOI: 10.18174/399762
|View full text |Cite
|
Sign up to set email alerts
|

Novel targets for the development of drugs for Type 2 Diabetes Mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 169 publications
(266 reference statements)
0
1
0
Order By: Relevance
“…The enzyme interacts with insulin receptors as well as substrate-1 of insulin receptors, thereby dephosphorylating phosphotyrosine residues and effecting down-regulation of insulin action. Type 2 drives the global pandemic, with an ever-increasing numbers of patients, accounting for 90% of all diabetes cases [9,15]. In addition, PTP1B overexpression has been implicated in the signaling of cancer, tumor and in inflammation processes [16][17][18].…”
Section: Introductionmentioning
confidence: 99%
“…The enzyme interacts with insulin receptors as well as substrate-1 of insulin receptors, thereby dephosphorylating phosphotyrosine residues and effecting down-regulation of insulin action. Type 2 drives the global pandemic, with an ever-increasing numbers of patients, accounting for 90% of all diabetes cases [9,15]. In addition, PTP1B overexpression has been implicated in the signaling of cancer, tumor and in inflammation processes [16][17][18].…”
Section: Introductionmentioning
confidence: 99%